Projects per year
Personal profile
Diplomas
Areas of expertise
Awards
Alfers Prize 2022
Namurois de l'année 2019
Eberhard F. Mammen - Young Investigator Award 2019
Prix Léo Pharma 2017 - Cancer et Thrombose
XXIV Congress of the International Society on Thrombosis and Haemostasis - Young Investigator Award
58th Annual SSC Meeting of the International Society on Thrombosis and Haemostasis - Young Investigator Award
55th American Society of Hematology Annual Meeting and Exposition - Abstract Achievement Award
56th American Society of Hematology Annual Meeting and Exposition - Abstract Achievement Award
External responsibilities
CEO of QUALIblood sa
Co-Chairman of the SSC Control of Anticoagulation of the Interntional Society on Thrombosis and Hemostasis
Pharmacovigilance Expert at the Federal Agency of Medicines and Health Products
Member of Expert Team Haemostasis Diagnostics at the ECAT Foundation
Member of the Expert Committee of the Assemblée Scientifique des Pharmaciens Francophones
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Doctor of Pharmacy, University of Namur
Award Date: 24 Oct 2015
Master of Pharmacy, Université Catholique de Louvain
Award Date: 24 Jun 2011
Bachelor of Pharmacy, University of Namur
Award Date: 4 Sept 2009
External positions
Member of the Expert Team Haemostasis Diagnostics, ECAT Foundation
Nov 2019 → …
Chief Executive Officer, Qualiblood
Nov 2017 → …
Co-Chairman, International Society on Thrombosis and Haemostasis
Nov 2016 → …
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
NucleoGlio (BioWin): Development of a diagnostic test for glioblastoma and follow-up of patients
1/11/23 → 31/10/27
Project: Research
-
PALPITATION: The platelet lipidome, a promising diagnostic or therapeutic option for HFpEF patients
Horman, S., POULEUR, A., Dessy, C. & Douxfils, J.
1/10/23 → 30/09/28
Project: Research
-
Management of (activated) factor eleven (FXI(a)) inhibitors
Vassart, J., Douxfils, J. & Dogne, J.
17/10/22 → …
Project: PHD
-
Clinical Pharmacology Research Group
Douxfils, J., Dogne, J., Musuamba Tshinanu, F., Masereel, B., Wieërs, G., Haguet, H., RONVAUX, L., Donis, N., Morimont, L., Evrard, J., Siriez, R., Gillot, C., FAVRESSE, J., BOUVY, C., Djokoto, H., Didembourg, M., David, C., Melchionda, S., Maloteau, V., Boucher, A., Devel, P., Modaffari, E., Vandeputte, M., De Messemaeker, A., Decarpentrie, J., Vassart, J. & De Groote, A.
1/04/22 → …
Project: Research Axis
-
The GLIOMARKERS project - development of biomarkers for the diagnostic and the prognostic of glioblastoma
Douxfils, J., RONVAUX, L., Donis, N., Maloteau, V. & Decarpentrie, J.
1/10/21 → …
Project: Research
-
A comparative in vitro study of the anticoagulant effect of branded versus generic rivaroxaban
Mangion, K., Vella, K., Gatt, A., Vella, A. M., Borg, M., Borg-Aquilina, D., Douxfils, J., Camilleri, L. & Riva, N., 24 Jan 2024, (E-pub ahead of print) In: Thrombosis Research. 235, p. 41-51 11 p.Research output: Contribution to journal › Article › peer-review
-
Algorithm for rapid exclusion of clinically relevant plasma levels of DOACs in patients using the DOAC Dipstick: An expert consensus paper
Harenberg, J., Gosselin, R. C., Cuker, A., Becattini, C., Pabinger, I., Poli, S., Weitz, J. I., Ageno, W., Bauersachs, R., Ćelap, I., Choi, P., Douketis, J., Douxfils, J., Elalamy, I., Fareed, J., Falanga, A., Favalor, E., Gerotziafas, G. T., Herkner, H., Hetjens, S., & 17 others , 5 Feb 2024, (E-pub ahead of print) In: Thrombosis and Haemostasis.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Biological variation of thrombin generation on ST Genesia
van Dievoet, M. A., Morimont, L., Bouvy, C., Gruson, D., Stephenne, X. & Douxfils, J., 22 Jan 2024, (E-pub ahead of print) In: International Journal of Laboratory Hematology. 10.111/ijlh.14232.Research output: Contribution to journal › Article › peer-review
-
Durability of humoral and cellular immunity six months after the BNT162b2 bivalent booster
Favresse, J., Gillot, C., Closset, M., Cabo, J., Wauthier, L., David, C., Elsen, M., Dogné, J-M. & Douxfils, J., Jan 2024, In: Journal of medical virology. 96, 1, p. e29365 10.1002/jmv.29365.Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Downloads (Pure) -
Hemostatic imbalance induced by tamoxifen in estrogen receptor-positive breast cancer patients: An observational study
Didembourg, M., Reda, S., Oldenburg, J., Rühl, H., Douxfils, J. & Morimont, L., 15 Jan 2024, In: International Journal of Laboratory Hematology. 9 p., 10.1111/ijlh.14242.Research output: Contribution to journal › Article › peer-review
Open Access
Datasets
-
Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: a systematic review and meta-analysis
Graux, C. (Contributor), Chatelain, C. (Contributor), Mullier, F. (Contributor), Haguet, H. (Contributor), Dogne, J. (Contributor) & Douxfils, J. (Contributor), Figshare, 29 Nov 2016
DOI: 10.6084/m9.figshare.4265168.v1, https://figshare.com/articles/Risk_of_arterial_and_venous_occlusive_events_in_chronic_myeloid_leukemia_patients_treated_with_new_generation_BCR-ABL_tyrosine_kinase_inhibitors_a_systematic_review_and_meta-analysis/4265168/1 and one more link, https://ndownloader.figshare.com/files/6948968 (show fewer)
Dataset
Prizes
-
55th ASH Annual Meeting and Exposition - Abstract Achievement Award
Douxfils, Jonathan (Recipient), 7 Dec 2013
Prize: Prize (including medals and awards)
-
56th ASH Annual Meeting and Exposition - Abstract Achievement Award
Douxfils, Jonathan (Recipient), 6 Dec 2014
Prize: Prize (including medals and awards)
-
58th Annual SSC Meeting of the ISTH - Young Investigators Awards
Douxfils, Jonathan (Recipient), 26 Jun 2012
Prize: Prize (including medals and awards)
-
Alfers 2022 - Prix de l'innovation
Douxfils, Jonathan (Recipient), 24 May 2022
Prize: Prize (including medals and awards)
-
Eberhard F. Mammen Young Investigator Award 2019
Douxfils, Jonathan (Recipient), 2019
Prize: National/international honour
Activities
-
Innovative applications of global assays in hemostatis
Jonathan Douxfils (Jury Member)
15 Dec 2023Activity: Examinations › External Thesis
-
Impact of progestagen alone or associated with estrogen on the coagulation: A state of the art in 2023
Jonathan Douxfils (Speaker)
1 Dec 2023Activity: Talk or presentation types › Invited talk
-
Hemostasis parameters with estetrol/drospirenone - why APC resistance matters
Jonathan Douxfils (Speaker)
30 Nov 2023Activity: Talk or presentation types › Invited talk
-
Safety profile of E4 Recent advance and evidence
Jonathan Douxfils (Invited speaker)
7 Nov 2023Activity: Talk or presentation types › Invited talk
-
Prediction of venous thromboembolism risk associated with combined oral contraceptives: an exploratory model
Laure Morimont (Speaker) & Jonathan Douxfils (Speaker)
30 Nov 2023Activity: Talk or presentation types › Oral presentation
Thesis
-
Evaluation of thrombotic and/or bleeding risks associated with anticoagulotherapy.
Author: Douxfils, J., 24 Oct 2015Supervisor: Dogne, J. (Supervisor), Mullier, F. (Supervisor), Masereel, B. (President), Chatelain, B. (Jury), Chatelain, C. (External person) (Jury), Verhamme, P. B. (External person) (Jury), TEN CATE, H. (External person) (Jury) & Ageno, W. (External person) (Jury)
Student thesis: Doc types › Doctor of Biomedical and Pharmaceutical Sciences
-
Therapeutic monitoring of new oral anticoagulant: focus on dabigatran
Author: Douxfils, J., 2012Supervisor: Dogne, J. (Supervisor)
Student thesis: Master types › Master in Pharmacy
Press/Media
-
University Hospital Bonn Reports Findings in Venous Thromboembolism (Hemostatic imbalance induced by tamoxifen in estrogen receptor-positive breast cancer patients: An observational study)
9/02/24
1 item of Media coverage
Press/Media: Expert Comment
-
New Findings from Karolinska Institute and Karolinska University Hospital in the Area of Female Contraceptive Agents Described (The benefits of estetrol addition to drospirenone for contraception)
6/11/23
1 item of Media coverage
Press/Media: Expert Comment
-
New blood test determines whether woman is eligible for contraceptive pill | Abroad
Laure Morimont & Jonathan Douxfils
24/07/23
1 item of Media coverage
Press/Media: Expert Comment
-
Catholic University of Louvain (UCLouvain) Researcher Describes Recent Advances in COVID-19 (Dexamethasone Modulates the Cytokine Response but Not COVID-19-Induced Coagulopathy in Critically Ill)
Christophe Beauloye & Jonathan Douxfils
28/04/23
1 item of Media coverage
Press/Media: Expert Comment
-
Data on COVID-19 Detailed by Researchers at University of Namur (Clinical Performance Evaluation of the Fluorecare? Sars-cov-2 & Influenza A/b & Rsv Rapid Antigen Combo Test In Symptomatic Individuals)
Jean-Michel Dogne & Jonathan Douxfils
28/04/23
1 item of Media coverage
Press/Media: Expert Comment